600 patients66,869 observations120 daysLIVE

Patient P-01855

Synthetic patientNBL-101 · Day 119 · 75+ · F · baseline S04Open companion preview
Therapy response
Declining
Tolerance
Favorable
GI state
Deteriorating
Inflammatory state
Favorable
Nutritional resilience
Favorable
Discontinuation risk
19%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 startedBaseline state S04
  2. Day 16 Trajectory diverged from predictionObserved response fell below the model's expected path.
  3. Day 32 DT-01 recommendedDosing / Timing Recommendation DT-01
  4. Day 33 Patient acceptedStarted DT-01 in the companion
  5. Day 38 GI symptom burden −15% vs expectedDosing / Timing Recommendation DT-01
  6. Day 44 Tolerance state changedUnstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 16.

Primary contributors, last 14 days
  • GI instability+5
  • Inflammatory activity-4
  • Treatment adherence-3
  • Toxicity+3

What helped?

  • Dosing / Timing Recommendation DT-01Day 32
    Result: symptom burden −15%
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients.

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure
  • Mucosal barrier integrity 30
    • MicrobiomeAkkermansia low → thinner mucus layer
  • Inflammatory signalling 25
    • DNAIL6 -174 variant raises baseline inflammatory tone
  • Butyrate / short-chain fatty acid production 25
    • MicrobiomeF. prausnitzii depleted
DNA
Fictional pharmacogenomic panel
  • IL6 -174 G/C
    Higher inflammatory tone
  • CYP2D6 Normal metabolizer
    Expected exposure
Microbiome
Shannon diversity 4.1 · butyrate capacity 66/100
  • Akkermansia muciniphilaLow
  • Faecalibacterium prausnitziiLow
  • Bacteroides fragilisNormal
  • Bifidobacterium longumNormal
  • EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
HRV
57 ms
Sleep
6.8 h
Steps
7,538
Resting HR
68 bpm
Daily log: GI score 21, nutritional resilience 69, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview
What to eat
  • Keep meals regular; three to four moderate portions spaced through the day
  • Include a cooked vegetable portion with each main meal
  • Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
  • Avoid known triggers for now: fried or oily food, dairy, alcohol
What to do
  • Log the daily check-in; one line is enough
  • Keep the current walking rhythm
  • Keep the sleep window steady
  • Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
  • Take the scheduled dose as agreed with your care team
  • No additional supplements this week
  • Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

PatientSimilarityBaselineInterventionOutcomeResponse today
P-0130850%S0477
P-0170050%S0977
P-0153549%S1972
P-0166448%S0380
P-0141145%S1884
P-0147545%S0476
P-0154545%S1675
P-0174945%S0466
P-0147944%S15DT-01improved84
P-0167344%S0476
P-0178444%S1684
P-0135542%S1469